Outcomes of Patients with Myeloproliferative Neoplasms (MPN) after Interferon-Alpha (IFN) Therapy Discontinuation

被引：0
|
作者：
Soret, Juliette
Cassinat, Bruno
Chevret, Sylvie
Dosquet, Christine
Giraudier, Stephane
Verger, Emmanuelle
Maslah, Nabih
Parquet, Nathalie
Chomienne, Christine
Kiladjian, Jean-Jacques
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3106.3106
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3106
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Interferon-Alpha (IFN) Therapy Discontinuation Is Feasible in Myeloproliferative Neoplasm (MPN) Patients with Complete Hematological Remission
    De Oliveira, Rafael Daltro
    Soret-Dulphy, Juliette
    Zhao, Lin-Pierre
    Marcault, Clemence
    Gauthier, Nicolas
    Verger, Emmanuelle
    Maslah, Nabih
    Parquet, Nathalie
    Raffoux, Emmanuel
    Vainchenker, William
    Chomienne, Christine
    Cassinat, Bruno
    Benajiba, Lina
    Kiladjian, Jean-Jacques
    BLOOD, 2020, 136
  • [2] Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone
    J-J Kiladjian
    S Giraudier
    B Cassinat
    Leukemia, 2016, 30 : 776 - 781
  • [3] Interferon-alpha for the therapy of myeloproliferative neoplasms: targeting the malignant clone
    Kiladjian, J-J
    Giraudier, S.
    Cassinat, B.
    LEUKEMIA, 2016, 30 (04) : 776 - 781
  • [4] RECOMBINANT INTERFERON-ALPHA THERAPY IN MYELOPROLIFERATIVE DISEASES
    KOS, M
    KORNINGER, C
    LECHNER, K
    NIESSNER, H
    PABINGER, I
    WIENER KLINISCHE WOCHENSCHRIFT, 1987, 99 (05) : 166 - 167
  • [5] Optimizing IFN Alpha Therapy against Myeloproliferative Neoplasms
    Hermange, Gurvan
    Cournede, Paul-Henry
    Plo, Isabelle
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 387 (01): : 31 - 43
  • [6] Real World Data on Safety and Efficacy of Pegylated Interferon (PEG-IFN) in Patients with Myeloproliferative Neoplasms (MPN)
    Garg, Mamta
    Agarwal, Siddharth
    Asagba, Graham
    BLOOD, 2023, 142
  • [7] Pegylated Interferon Alpha-2a in Patients with Myeloproliferative Neoplasms (MPN): International Experience in 115 Cases
    Gowin, Krisstina
    Thapaliya, Prakash
    Samuelson, J.
    Harrison, C. N.
    Radia, Deepti
    Andreasson, Bjorn
    Mascarenhas, John
    Rambaldi, Alessandro
    Barbui, T.
    Rea, Catherine J.
    Camoriano, John
    Gentry, A.
    Kiladjian, Jean-Jacques
    O'Connell, Casey L.
    Mesa, Ruben A.
    BLOOD, 2011, 118 (21) : 1215 - 1215
  • [8] ALL-TRANS RETINOIC ACID POTENTIATES THE INHIBITORY EFFECTS OF INTERFERON ALPHA (IFN) ON CHRONIC MYELOPROLIFERATIVE NEOPLASMS (MPN) PROGENITORS IN VITRO
    Pugliese, N.
    Quintarelli, C.
    De Angelis, B.
    Errichiello, S.
    Marano, L.
    Raia, M.
    Cerchione, C.
    Del Vecchio, L.
    Picardi, M.
    Martinelli, V.
    Pane, F.
    HAEMATOLOGICA, 2013, 98 : 110 - 110
  • [9] Interferon-alpha and hydroxyurea in the therapy of hyperthrombocytosis, associated with myeloproliferative disorders
    Khoroshko, ND
    Tsvetaeva, NV
    Turkina, AG
    Zhuravlev, VS
    Lukina, EA
    Semenova, EA
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 313 - 313
  • [10] Interferon-alpha and the pathogenesis of myeloproliferative disorders
    Voutsadakis, IA
    MEDICAL ONCOLOGY, 2000, 17 (04) : 249 - 257
12345